Literature DB >> 6350178

Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement.

M C Cerquetti, D O Sordelli, R A Ortegon, J A Bellanti.   

Abstract

Mice of the C5-deficient DBA/2J and B10.D2/oSnJ inbred strains were aerosolized with Staphylococcus aureus, and the pulmonary clearance of bacteria was determined 4 h later. Both C5-deficient strains had a significantly decreased lung clearance of S. aureus compared with their genetically closest C5-sufficient relatives, DBA/1J and B10.D2/nSnJ strains, respectively. Serum hemolytic activity and pulmonary clearance of S. aureus were also investigated in F1 and F2 progenies (DBA/1J X DBA/2J and DBA/2J X B10.D2/oSnJ). Serum hemolytic activity was present in all F1 (DBA/1J X DBA/2J) mice, and their pulmonary clearance of S. aureus was no different from that of the C5-sufficient parents (DBA/1J). The absence of serum hemolytic activity (absence of C5) in all mice from F1 and F2 (DBA/2J X B10.D2/oSnJ) and 20% of the F2 (DBA/1J X DBA/2J) was related to a decreased lung clearance of S. aureus. These results are consistent with an autosomal recessive pattern of heredity for the murine abnormality in pulmonary clearance of S. aureus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6350178      PMCID: PMC264609          DOI: 10.1128/iai.41.3.1071-1076.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  A QUANTITATIVE STUDY OF THE DEPOSITION AND CLEARANCE OF BACTERIA IN THE MURINE LUNG.

Authors:  G A LAURENZI; L BERMAN; M FIRST; E H KASS
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

2.  Activity of mouse complement.

Authors:  L T ROSENBERG; D K TACHIBANA
Journal:  J Immunol       Date:  1962-12       Impact factor: 5.422

3.  Phagocyte strategy vs. microbial tactics.

Authors:  P Densen; G L Mandell
Journal:  Rev Infect Dis       Date:  1980 Sep-Oct

4.  Nonphagocytic clearance of Staphylococcus aureus from murine lungs.

Authors:  K M Nugent; E L Pesanti
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

5.  Mechanisms of complement-mediated clearance of bacteria from the murine lung.

Authors:  P J Heidbrink; G B Toews; G N Gross; A K Pierce
Journal:  Am Rev Respir Dis       Date:  1982-05

6.  Comparative role of complement in pneumococcal and staphylococcal pneumonia.

Authors:  J D Coonrod; K Yoneda
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

7.  Enhancement of Pseudomonas aeruginosa lung clearance after local immunization with a temperature-sensitive mutant.

Authors:  D O Sordelli; M C Cerquetti; A M Hooke; J A Bellanti
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

8.  THE ROLE OF THE ALVEOLAR MACROPHAGE IN THE CLEARANCE OF BACTERIA FROM THE LUNG.

Authors:  G M GREEN; E H KASS
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

9.  Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages.

Authors:  D E Chenoweth; M G Goodman; W O Weigle
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

10.  Deficiency of the fifth component of complement in mice with an inherited complement defect.

Authors:  U R Nilsson; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

View more
  9 in total

1.  Differences in susceptibility of inbred mice to Bacillus anthracis.

Authors:  S L Welkos; T J Keener; P H Gibbs
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

2.  Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds.

Authors:  M C Cerquetti; D O Sordelli; J A Bellanti; A M Hooke
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

3.  Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages.

Authors:  Kari R Wilson; Jennifer M Napper; James Denvir; Vincent E Sollars; Hongwei D Yu
Journal:  Microbiology       Date:  2007-04       Impact factor: 2.777

4.  Functional basis for complement evasion by staphylococcal superantigen-like 7.

Authors:  Jovanka Bestebroer; Piet C Aerts; Suzan H M Rooijakkers; Manoj K Pandey; Jörg Köhl; Jos A G van Strijp; Carla J C de Haas
Journal:  Cell Microbiol       Date:  2010-10       Impact factor: 3.715

5.  Staphylococcus aureus virulence is enhanced by secreted factors that block innate immune defenses.

Authors:  Ilse Jongerius; Maren von Köckritz-Blickwede; Malcolm J Horsburgh; Maartje Ruyken; Victor Nizet; Suzan H M Rooijakkers
Journal:  J Innate Immun       Date:  2012-02-07       Impact factor: 7.349

6.  Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia.

Authors:  Warren E Rose; Jens C Eickhoff; Sanjay K Shukla; Madhulatha Pantrangi; Suzan Rooijakkers; Sara E Cosgrove; Victor Nizet; George Sakoulas
Journal:  J Infect Dis       Date:  2012-09-10       Impact factor: 5.226

7.  Endobronchial inflammation following Pseudomonas aeruginosa infection in resistant and susceptible strains of mice.

Authors:  C Morissette; E Skamene; F Gervais
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

8.  Replication rate of Pseudomonas aeruginosa in the murine lung.

Authors:  D O Sordelli; M C Cerquetti; A M Hooke
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

9.  Two genes on A/J chromosome 18 are associated with susceptibility to Staphylococcus aureus infection by combined microarray and QTL analyses.

Authors:  Sun-Hee Ahn; Hitesh Deshmukh; Nicole Johnson; Lindsay G Cowell; Thomas H Rude; William K Scott; Charlotte L Nelson; Aimee K Zaas; Douglas A Marchuk; Sehoon Keum; Supaporn Lamlertthon; Batu K Sharma-Kuinkel; Gregory D Sempowski; Vance G Fowler
Journal:  PLoS Pathog       Date:  2010-09-02       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.